ARTICLE | Clinical News
Provir: Started a Phase II trial
January 31, 1994 8:00 AM UTC
Shaman Pharmaceuticals Inc. (SHMN), South San Francisco Product: Provir, oral antiviral compound Indication: Respiratory syncytial virus (RSV) Status: Started a Phase II trial in hospitalized children...